Fri, June 28, 2024
Thu, June 27, 2024
Wed, June 26, 2024
Tue, June 25, 2024
Mon, June 24, 2024

Subbu Nambi Downgraded (TXG) to Hold on, Jun 26th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. mbi-downgraded-txg-to-hold-on-jun-26th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Subbu Nambi of Guggenheim, Downgraded "10x Genomics, Inc." (TXG) to Hold on, Jun 26th, 2024.

Subbu has made no other calls on TXG in the last 4 months.



There are 9 other peers that have a rating on TXG. Out of the 9 peers that are also analyzing TXG, 4 agree with Subbu's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Tycho Peterson of "Jefferies" Initiated at Hold and Held Target at $24 on, Monday, June 3rd, 2024
  • Dan Brennan of "TD Cowen" Downgraded from Strong Buy to Hold and Decreased Target to $32 on, Wednesday, May 1st, 2024
  • Dan Leonard of "UBS" Maintained at Hold with Decreased Target to $30 on, Wednesday, May 1st, 2024
  • Derik De Bruin of "B of A Securities" Maintained at Hold with Decreased Target to $36 on, Wednesday, May 1st, 2024


These are the ratings of the 5 analyists that currently disagree with Subbu


  • Matthew Sykes of "Goldman Sachs" Maintained at Strong Sell with Decreased Target to $26 on, Wednesday, May 1st, 2024
  • Daniel Arias of "Stifel" Maintained at Strong Buy with Decreased Target to $53 on, Wednesday, May 1st, 2024
  • Kyle Mikson of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $50 on, Monday, April 29th, 2024
  • Justin Bowers of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $55 on, Thursday, April 18th, 2024
  • Luke Sergott of "Barclays" Maintained at Buy with Decreased Target to $45 on, Wednesday, April 10th, 2024

Publication Contributing Sources